No Photo Available

Last Update

2017-03-13T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Mark Baker?

Mr. Mark R. Baker

Chief Executive Officer

Progenics Pharmaceuticals , Inc.

Direct Phone: (646) ***-****       

Email: m***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Progenics Pharmaceuticals , Inc.

777 Old Saw Mill River Road

Tarrytown, New York 10591

United States

Company Description

Progenics Pharmaceuticals, Inc. is developing innovative medicines and other products for targeting and treating cancer, with a pipeline that includes several product candidates in later-stage clinical development. These products in development include th ... more

Find other employees at this company (168)

Background Information

Employment History

President

Saratoga LLC

Economist

OECD

Cover Supervisor and Learning Support Assistant

Highdown School and Sixth Form Centre

Learning Support Assistant - VI Unit

Highdown School

Application Engineer

Jaguar Land Rover

Supply Cover Supervisor

The Capita Group Plc

Economist

Reserve Bank of Australia

Partner and Co-Chairman of the Capital Markets Group

Dewey Ballantine LLP

Executive Vice President, Chief Legal Officer and Secretary

ContiGroup Companies , Inc.

Chief Business Officer

New York Water Taxi

Software Engineer

Continental Corporation

Affiliations

Board Member
EXINI Diagnostics AB

Member of the Board, Member
Saab AB

Committee Member
The Allegiance Bowl Committee Inc

Advisory Board Member
Wilton Wildlife Preserve & Park

Board Member
Saratoga Convention & Tourism Bureau

Admissions Advisor
Reading College

Education

A.B. degree

History and Biochemistry

Columbia College

J.D.

Columbia University School of Law

Web References (171 Total References)


Board of Directors - Progenics

www.progenics.com [cached]

Mark R. Baker

CEO
Mr. Baker joined the Company in 2005 as Senior Vice President & General Counsel and Secretary. In 2008, he was appointed Executive Vice President - Corporate, in 2009 became President, and has been CEO since March 2011. From 2003 to 2005, Mr. Baker was Chief Business Officer, Secretary and a director of New York Trans Harbor LLC, a privately-held ferry operation in New York City. From 1997 to 2001, he was Executive Vice President, Chief Legal Officer and Secretary of Continental Grain Company, a privately-held international agri-business and financial concern. Prior thereto, he was a partner and Co-Chairman of the Capital Markets Group of the New York law firm, Dewey Ballantine. Mr. Baker has an A.B. degree from Columbia College and a J.D. from the Columbia University School of Law.


Management Team - Progenics

www.progenics.com [cached]

Mark R. Baker

Chief Executive Officer
Mr. Baker joined the Company in 2005 as Senior Vice President & General Counsel and Secretary. In 2008, he was appointed Executive Vice President - Corporate, in 2009 became President, and has been CEO since March 2011. From 2003 to 2005, Mr. Baker was Chief Business Officer, Secretary and a director of New York Trans Harbor LLC, a privately-held ferry operation in New York City. From 1997 to 2001, he was Executive Vice President, Chief Legal Officer and Secretary of Continental Grain Company, a privately-held international agri-business and financial concern. Prior thereto, he was a partner and Co-Chairman of the Capital Markets Group of the New York law firm Dewey Ballantine. Mr. Baker has an A.B. degree from Columbia College and a J.D. from the Columbia University School of Law.


"The initiation of this trial reflects ...

ir.progenics.com [cached]

"The initiation of this trial reflects our commitment to advancing PSMA-targeted candidates that have the potential to transform how prostate cancer is detected, managed and treated," said Mark Baker, CEO of Progenics.  "The insights we gain from this trial will help guide the design of the future clinical development program of 1095."


"This transaction significantly advances ...

nordiclifescience.org [cached]

"This transaction significantly advances our efforts to develop products which transform the way we diagnose, monitor and treat cancer," states Mark Baker, CEO of Progenics.


"The growing acceptance of active ...

ir.progenics.com [cached]

"The growing acceptance of active surveillance among men with lower-grade prostate cancer presents a significant opportunity for 1404 to enable clinicians and patients to accurately and non-invasively visualize and manage their disease," said Mark Baker, Chief Executive Officer of Progenics.

...
Mr. Baker continued, "Our modification to the protocol reflects emerging trends among men with low grade disease to increasingly favor the use of active surveillance versus more aggressive measures, consistent with treatment guidelines.  We believe that this shift underscores the potential for agents such as 1404 to address the growing active surveillance market.

Similar Profiles

Other People with this Name

Other people with the name Baker

Brad Baker
Kerr Industries Limited

Cristi Baker
Accountemps

Daniel Baker
Holder Construction Company

Dorion Baker
Engility Corporation

Alexandra Baker
The Management Trust

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory